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Cryptotanshinone attenuates in vitro oxLDL-induced pre-lesional atherosclerotic 
events. 
ABSTRACT 
Development of early stage atherosclerosis involves the activation of endothelial cells by 
oxidized low-density lipoprotein (oxLDL) with subsequent increases in endothelial 
permeability and expression of adhesion molecules favoring the adherence of monocytes to 
the endothelium. Cryptotanshinone (CTS), a major compound derived from the Chinese herb 
Salvia miltiorrhiza, is known for its protective effects against cardiovascular diseases. The 
aim of this study was to determine whether CTS could prevent the oxLDL-induced early 
atherosclerotic events. OxLDL (100 µg/mL) was used to increase endothelial permeability 
and induce monocyte-endothelial cell adhesion in human umbilical vein endothelial cells 
(HUVECs). Endothelial nitric oxide (NO) concentrations, a permeability-regulating 
molecule, and expressions of intercellular adhesion molecule-1 (ICAM-1) and vascular cell 
adhesion molecule-1 (VCAM-1) were measured. Results show that a) endothelial 
hyperpermeability was suppressed by 94 % (p < 0.005), b) monocyte adhesion by 105 % 
(p < 0.01), and c) ICAM-1 and VCAM-1 expressions by 90 % (p < 0.01) and 150 % 
(p < 0.005), respectively, when CTS was applied. In contrast, CTS increased NO levels by 
129 % (p < 0.01) and was found to be noncytotoxic in the concentrations between 1-10 µM. 
These findings indicate that CTS suppresses an increase in endothelial permeability, likely 
due to the restoration of NO bioavailability in endothelial cells. They also indicate that CTS 
may attenuate monocyte adhesion to endothelial cells through the inhibition of adhesion 
molecules' expression. Thus, CTS may play an important role in the prevention of early or 
pre-lesional stage of atherosclerosis. 
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